Literature
首页EnglishHealth News

C. diff Epidemic: What You Must Know

来源:WebMD Medical News
摘要:diffhasbeenmakingpeoplesickin38U。diffsickensaboutahalfmillionAmericanseveryyear,andeveryyeartheepidemicgetsabout10%bigger,CDCmedicalepidemiologistL。diff。diffasuperbug。...

点击显示 收起

May 30, 2008 -- While bird flu and MRSA have been making headlines, a dangerous strain of C. diff has been making people sick in 38 U.S. states.

C. diff sickens about a half million Americans every year, and every year the epidemic gets about 10% bigger, CDC medical epidemiologist L. Clifford McDonald, MD, tells WebMD.

Bigger -- and more deadly. The death rate is soaring by 35% a year.

From 1999 to 2004, the bug became four times more lethal, with death rates increasing from 5.7 per million Americans to 23.7 per million Americans in 2004. During one hospital outbreak in Quebec, Canada, the one-year death rate hit 17%.

What's going on? WebMD has answers to these important questions:

How bad is C. diff?

C. diff disease can range from mild diarrhea to life-threatening colitis. The bug produces toxins that destroy the mucosal lining of the gut.

There are many different C. diff strains circulating in the U.S. But since 2000, one of these strains has gone from a minor player to become the most frequently isolated C. diff strain. The strain has several names. Referring to its genetic fingerprint, the CDC calls it NAP1. In Europe and Canada, it's often called the 027 or BI strain.

The NAP1 strain of C. diff took off shortly after it acquired resistance to fluoroquinolone antibiotics. There's some evidence it may also have acquired some resistance to Flagyl, one of the two antimicrobial agents used to treat it (the other is vancomycin).

Antibiotic resistance isn't the only worrisome thing about NAP1. C. diff normally makes two toxins. The NAP1 strain makes 16 times more toxin A and 23 times more toxin B. And it also makes another toxin, called binary toxin, although it's not yet clear how this toxin affects humans.

To date, the NAP1 strain has been reported in 37 U.S. states and in the District of Columbia.

A recent report shows that adult C. diff hospitalizations doubled between 2000 and 2005 to about 300,000 hospitalizations a year. That's more hospitalizations than are seen with MRSA, which sends about 126,000 Americans to the hospital each year.

The CDC's C. diff expert, L. Clifford McDonald, MD, tells WebMD that if you count pediatric C. diff cases and cases in the community that do not enter the hospital, there are probably half a million U.S. cases of C. diff infection each year.

And yes, it is an epidemic: The infection rate is going up by about 10% a year. But the death rate is going up even faster, says Marya Zilberberg, MD, adjunct professor at the University of Massachusetts, Amherst, and president of the EviMed Research Group.

"The disease appears to be more likely to be fatal … nearly doubling from a 1.2% to a 2.2% case fatality rate," Zilberberg tells WebMD.

During a hospital outbreak in Canada, the one-year mortality rate for C. diff infection was 17%.

"We're seeing increases both regionally and nationally in death certificates listing C. diff infection," McDonald says. "And hospitals are saying the same thing."

There are actually three ongoing C. diff epidemics. One is in hospitals. Another is in the community. And a third is in livestock.

作者: 2008-6-1
医学百科App—中西医基础知识学习工具
  • 相关内容
  • 近期更新
  • 热文榜
  • 医学百科App—健康测试工具